This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Erysipelas, Impetigo, Herpes Zoster, Molluscum Contagiosum, Warts, Tinea, Melanoma, Actinic Keratosis, Basal Cell Carcinoma or Squamous Cell Carcinoma
and you are
between 18 and 99
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to demonstrate the validity and utility of a tele-dermatology system in the midterm periodic screening of non-widespread skin lesions of recent onset or for which a specialized early classification is deemed to change the prognosis - including precancerous skin lesions as well as melanoma and non-melanoma skin cancers - compared to control visits at fixed follow-up.

Provided treatments

  • Procedure: Screening
  • Device: Tele-dermatology

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02902822. The sponsor of the trial is Centro Studi Gised and it is looking for 461 volunteers for the current phase.
Official trial title:
Tele-dermatology of Skin Cancer: a Randomized Trial Comparing Remote Assessment With Conventional Visits in a Cohort of Local Health Authority Employees in the Province of Bergamo (the Shoot the Mole Study)